Industry NewsGlox Therapeutics secures £4.3M seed funding to develop precision antimicrobials targeting drug-resistant bacteria
Industry NewsBeckman Coulter Life Sciences and Pillar Biosciences announce NGS application development pipeline for the Biomek NGeniuS System
Industry NewsIntegrated DNA Technologies opens new therapeutic manufacturing facility to support growing demand in genomic medicine
Editorial ArticlePost-translational modification research offers new insights into health and disease